Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Proof will be in the pudding.

<< Previous

Bullboard Posts

Next >>

Comment by Kswdeluxon Nov 07, 2022 9:59am

179 Views

Post# 35078652

RE:RE:Proof will be in the pudding.

canadafan wrote: Todayas resutls 3X normal standard of care! steller
More to come next week, to discusss phase 2/3 enrolment with a potential partner

Given the urgent need for novel therapies in pancreatic cancer, I believe this exciting finding highlights an opportunity for pelareorep to transform the standard of care."

To transform the standard of care! That from the Dr that is running the Goblet trail independent of ONCY under the direction of ROCHE.

I expected that much of the discussion would not be in today's NR, as I expected them to hold that until the Presentations on the 11th, etc. so got more than I was hoping for, for today.

So as ONC noted, I am expecting more defined data and heightened discussion between now and Nov 14th. Very exciting! As high as 70-90% ORR on two individuals, with 7 of 10 responding.

What was released today is very positive.

Nasdaq daily average volume was exceeded in less than 15 min this morning.

Curious to see where that goes between now and the 14th.